Purpose: Overuse of antibiotics is of concern, but may differ between European countries. This study compares outpatient use of oral antibiotics between Germany (DE) and the Netherlands (NL). The use of systemic antibiotics is subject to continuous surveillance to understand antibiotic resistance development.
diseases effectively. 3 Thus, restrained use of antimicrobial medicines is urgently advocated worldwide. The focus of improvement programs in human medicine should be on outpatient prescribing of antibiotics since during recent years, 85% to 95% of antibiotics have been dispensed in the community in many countries worldwide. 1, 4 Numerous studies have quantified the overall use of systemic antibiotics and elucidated specific antibiotic groups or substances in European countries 5 and use in different age groups. [6] [7] [8] [9] [10] Within the European Union, Germany (DE) and the Netherlands (NL) belong to countries with a low antibiotic consumption. 2 Both countries are culturally comparable, in direct geographical neighborhood, and with highly developed health care systems. However, antibiotic consumption was substantially higher in DE during recent years compared with NL. 1, 11, 12 National preferences for types of antibiotics prescribed in both countries, with the exception of penicillins as the antibiotic drug class mostly prescribed, differed strongly between 2004 and 2015.
Most strikingly, cephalosporins were hardly used at all in NL whereas their use has increased in DE. 13, 14 In DE, most patients who received an antibiotic in ambulatory care in 2008 were diagnosed with respiratory tract (RTI) or genitourinary tract infections whereas in NL other diagnoses were more frequent. 13 The application of broad spectrum agents for viral self-limiting infections is of concern in DE, especially in children and adolescents. 8 In-depth and contemporary studies, however, are lacking, which may help to understand the reasons for the differences for outpatient oral antibiotics dispensings in both countries, eg, by looking at national guideline recommendations.
The goal of our study was, therefore, to compare directly the outpatient use of oral antibiotics in DE and NL during the 5-year period 2012
to 2016 and by age groups, antibiotic classes, and individual drugs in particular. We further aimed at comparing actual guideline recommendations for the two countries for RTI and urinary tract infections (UTI).
Since in DE frequent prescribing of clindamycin by dentists had been observed, [15] [16] [17] [18] [19] another focus of the study was dispensing of clindamycin by dentists and the guidelines for odontogenic infections in DE.
2 | METHODS
| Study design
A longitudinal drug utilization study 20 for oral antibiotic use during the years 2012 and 2016 was performed.
| Data sources
In DE, information was available from the DAPI database, which contains anonymous claims data of drugs prescribed and subsequently dispensed at community pharmacies at the expense of the Statutory Health Insurance (SHI) Funds. Nearly 87% of DE's population is insured by the SHI system. 21, 22 The database covers all claims data from a representative sample of more than 80% of the community pharmacies throughout all regions. Dispensing data were linked to the ABDA database containing information about the (brand) name, composition, active ingredient, strength, package size, dosage form, and route of administration of German medicinal products. 23 Prescriptions by dentists could be identified by a specific code on the prescriptions.
Prescriptions for privately insured patients and payed out-of-pockets are not available in the DAPI database. Data on indication, treatment duration, or dosages as well as data on individual patients including gender are also not available, except for year of birth.
In NL, data were available from the Dutch Foundation for Pharmaceutical Statistics (SFK) that collects dispensing data for drugs prescribed from nearly 95% of all community pharmacies. 24 All prescriptions are registered for the concerning patient in the computer system of the pharmacy. This registration is mandatory in NL to achieve a complete file on all patient's medication in use, regardless of the insurance status. Besides, all inhabitants are covered by a mandatory health insurance system. These data provide detailed information on the drugs prescribed, including the codes from the Anatomical Therapeutic Chemical (ATC) classification system of the WHO, 25 and the amount dispensed.
Thus, information on (brand) name, composition, active ingredient, strength, package size, dosage form, and route of administration for the dispensed antibiotics was available in the database of the SFK for each individual antibiotic product on patient level. In the SFK, patients are coded by an anonymous number from the computer system of the local pharmacy. The only information further available is on patient's gender and year of birth. Detailed information about the specialty of the prescriber and the reason for prescribing is not available.
In both countries, oral antibiotics are prescription-only and reimbursed by health insurance funds. In DE, data were extrapolated by regional factors based on 80% to 100% of all community pharmacies, and thus 100% of the SHI insured population. In NL, data were extrapolated from 95% available to 100% of the community pharmacies, and thus 100% of the total population. To enhance comparability, in NL, the extrapolated data were related to the total population in the NL, whereas in DE the extrapolated data were related to the SHI insured population. body of all dentists in DE. 30 Only current guidelines were included, those with expired date were not taken into account. In NL, guidelines for general practitioners are consolidated by the Dutch College of General Practitioners, Nederlands Huisartsen Genootschap (NHG), and they were extracted from their website. 31 3 | RESULTS
| Measurement of antibiotic use

| Overall use of antibiotics
Since 2012, the overall consumption of oral antibiotics showed a nonsignificant decrease of −2.2% in DE and −6.9% in NL (Table 1 and (Table 2 ).
| Use of major classes of antibiotics in 2016
Penicillins were the most frequently used oral antibiotic class in both countries (4.89 DID in DE, 3.97 in NL) ( Table 1) 
| Use of individual antibiotics
Seven of the 10 most frequently used oral antibiotics in 2016 were in agreement in both countries. Amoxicillin was the most frequently used oral antibiotic in both countries, followed by cefuroxime and doxycycline in DE and by doxycycline and amoxicillin with enzyme inhibitor in NL (Table 3) . Three of the 10 most frequently used oral antibiotics in both countries (ciprofloxacin, azithromycin, and clarithromycin) belong to the "Watch group antibiotics" according to the WHO. Oral fosfomycin showed the highest increase from 2012 to 2016 in both countries (87% in DE, 257% in NL, Table 4 ). In NL, a lot of attention is given for cautious use of antibiotics.
| Overview of guidelines for antibiotic use
General practitioners (GPs) act as gatekeepers in outpatient care and are educated to a reserved antibiotic prescribing according to their guidelines. 49 This may explain the lower outpatient antibiotic dispensing rates, compared with DE. For example, a study for antibiotic There are also no large differences with respect to restrictive use of clindamycin, chinolones, and cephalosporins.
We have no evidence for differences in infection prevalence in both countries (eg, respiratory diseases 54 ) which would justify the huge discrepancies in, for example, use of cefuroxime or clindamycin between NL and DE. The use of oral cefuroxime is only justified for pathogens (except for UTI) with a minimum inhibitory concentration well below 1 μg/mL, which is the case for, eg, Streptococcus pneumoniae. Many other pathogens require much higher concentrations of cefuroxime which cannot be reached with approved oral products. 55 The high consumption for oral cephalosporins in outpatients in DE corresponds with earlier findings for all cephalosporins and suggests overuse. 56 Due to actual resistance patterns and more side effects compared with penicillins, in German guidelines for dental diseases, clindamycin is only recommended in case of penicillin allergy or as second choice treatment. 39 This recommendation does not match with the high dispensing rates for prescriptions by dentists. Overprescription of clindamycin by German dentists has been described before. 57, 58 Our data suggest, however, that guideline adherence by dentists may have improved over the past years.
According to the summary of product characteristics, fosfomycin is primarily prescribed for UTI in women. Although we could not analyze fosfomycin use by gender, the fact that the use of oral fosfomycin remarkedly increased in both countries let us assume it is German College of General Practitioners and Family Physicians.
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increasingly used for this indication. For UTI in women, it can replace fluoroquinolones, cephalosporins, and co-trimoxazol, in line with guidelines for treatment of uncomplicated UTI (guideline in NL since 2013). 59, 60 The latter are associated with a higher risk of side effects and a selection of multiresistant pathogens.
59,61
| Strengths and limitations
The strength of employing pharmacy claims-based databases for drug utilization studies is the access to a very large study population. Both databases dispose of information on dispensings to the majority of the population in DE and NL. It should be noted that the study was limited to the population insured by the SHI system in DE and that dispensings of antibiotics to privately insured patients were not included. This might have introduced a bias in the comparison with NL. However, this is not expected to be substantial. Another particular strength of the DAPI and the SFK databases is actuality of their data enabling us to cover the most recent period.
A major shortcoming of our study is that individual patient data such as prescribed doses for DE and information on diagnosis for both countries were lacking and comparison of antibiotic use was limited to overall dispensing data. Differences in consumption between both countries may thus originate in differences in absolute patient numbers treated per 1000 in the total population as well as in differences in dose or therapy duration of the antibiotics. We have noted that recommendations for antibiotic use in Dutch guidelines for treatment of RTI were more conservative with respect to dose in some cases, eg, for otitis media and amoxicillin, 34, 44 but without individual patient data the extent of such effects is merely speculative. A further limitation is that analyses of age groups were hampered by a potential underestimation of the group 0 to 1 years of age since exact date of birth was not available. However, since in both countries the algorithm for assigning the year of age to a prescription was similar, the extent of underestimation is comparable in both countries. Dispensing data, finally, are only a surrogate for drug use because how many units of the packages dispensed are actually taken is unknown. 
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